Concepedia

Lydia Wunderle

LW

10

Publications

2.1K

Citations

10

H-Index

2005

Active since

Affiliations

Goethe University Frankfurt(Current)

Heidelberg University

University Hospital Frankfurt

University Medical Centre Mannheim

University Hospital Schleswig-Holstein

Lydia Wunderle is an author at Goethe University Frankfurt specializing in cancer research, oncology, and tumor biology.

Top concepts

Publications per year

2005–2020

10

Publications

10

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Anna Pavlova, Lydia Wunderle, Johannes Oldenburg et al. · Blood · 2007 · 249 citations · Full text

Imatinib compared with chemotherapy as front‐line treatment of elderly patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ALL)

Oliver G. Ottmann, Aristoteles Giagounidis, Matthias Stelljes et al. · Cancer · 2007 · 237 citations · Full text

Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation

Katharina Raum, Sandra Marković, Verena Nowak et al. · Blood · 2018 · 73 citations · Full text

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

Thoralf Lange, Sylvia Wystub, Jacqueline Maier et al. · Leukemia · 2012 · 67 citations

, , +8

Rows per page

1–5 of 10